C

Cartesian Therapeutics

25 employees

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Gene Therapy
NETs
Cell Therapy
Myasthenia Gravis
Oncology
ARDS
multiple myeloma
Cancer Research
Autoimmune Diseases
Cardiovascular Disease
Immunotherapy
Immunology
Molecular Biology
Lung disease

Date founded

2016

Funding rounds raised

Total raised

$2M

from 2 investors over 2 rounds

C

Cartesian Therapeutics raised $2M on May 4, 2021

Investors: National Heart, Lung, and Blood Institute

C

Cartesian Therapeutics raised undisclosed on January 1, 2016

Investors: Schooner Capital

FAQ